New Analysis Finds the Medicare Drug Price Negotiation Program Threatens Financial Stability of American Pharmacies ...

Biden-era policies rescinded by Donald Trump could signal a significant shake-up in Medicare and Medicaid drug price reforms.

In Budget 2024, the government slashed GST (Goods and Services Tax) from three major cancer drugs: Trastuzumab Deruxtecan, ...

NPPA calls for price data on diagnostic agent iohexol following DoP's review order: Gireesh Babu, New Delhi Thursday, January 23, 2025, 08:00 Hrs [IST] The National Pharmaceutical ...

Sri Lanka’s attempt to emulate India’s pharmaceutical pricing system is a cautionary tale of misplaced ambition ...

The National Pharmaceutical Pricing Authority (NPPA) has requested data on prices to retailers and annual turnover from ...

The Biden administration’s selection of 15 new drugs for price negotiations is reigniting the call from opponents to amend how drugs can be selected for the Medicare program.

Federal officials are targeting the blockbuster drugs as part of their ongoing initiative to lower drug costs.

This past year featured key developments in the prescription drug policy area, including the implementation of significant ...

Columbus joined a slough of cities, states and counties in suing drug companies and pharmacy benefit managers who they say artificially raised insulin prices for decades and profited from it ...